T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Scholastic
SCHL
$784M
| $175M | 0.04% |
3,961,522
+597,862
| +18% | +$25.7M |
|
|
AVNS
477
DELISTED
Avanos Medical
AVNS
| $174M | 0.04% |
4,301,760
+962,790
| +29% | +$43.2M |
|
478
HubSpot
HUBS
$12B
| $171M | 0.04% |
3,446,943
+1,900,933
| +123% | +$87.2M |
|
|
USG
479
DELISTED
Usg
USG
| $170M | 0.03% |
6,104,050
+38,200
| +0.6% | +$1.05M |
|
480
Capitol Federal Financial
CFFN
$1.09B
| $169M | 0.03% |
14,066,270
+7,017
| +0% | +$85.4K |
|
481
PPG Industries
PPG
$25.5B
| $169M | 0.03% |
1,475,454
-462,034
| -24% | -$52.8M |
|
482
EastGroup Properties
EGP
$11B
| $168M | 0.03% |
2,990,920
+141,280
| +5% | +$8.2M |
|
483
Mine Safety
MSA
$7.32B
| $168M | 0.03% |
3,457,339
-148,200
| -4% | -$7.11M |
|
|
CSC
484
DELISTED
Computer Sciences
CSC
| $166M | 0.03% |
5,997,136
-357,136
| -6% | -$10M |
|
|
GWR
485
DELISTED
Genesee & Wyoming Inc.
GWR
| $165M | 0.03% |
2,166,598
-98,740
| -4% | -$8.7M |
|
|
FNGN
486
DELISTED
Financial Engines, Inc.
FNGN
| $163M | 0.03% |
3,847,035
+62,746
| +2% | +$2.67M |
|
487
Radian Group
RDN
$4.92B
| $161M | 0.03% |
8,601,508
+40,640
| +0.5% | +$730K |
|
488
Kemper
KMPR
$1.59B
| $161M | 0.03% |
4,174,224
+79,560
| +2% | +$3M |
|
489
NewMarket
NEU
$8.72B
| $160M | 0.03% |
359,441
-983
| -0.3% | -$452K |
|
|
BERY
490
DELISTED
Berry Global Group, Inc.
BERY
| $159M | 0.03% |
5,336,807
-288,469
| -5% | -$9.07M |
|
491
Trane Technologies
TT
$105B
| $158M | 0.03% |
2,349,774
-709,494
| -23% | -$48.6M |
|
492
M&T Bank
MTB
$36.6B
| $158M | 0.03% |
1,263,044
-72,164
| -5% | -$8.89M |
|
493
United Therapeutics
UTHR
$21.5B
| $157M | 0.03% |
902,012
-32,254
| -3% | -$5.8M |
|
|
TRAK
494
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
| $157M | 0.03% |
2,496,920
-185,600
| -7% | -$8.27M |
|
|
RTN
495
DELISTED
Raytheon Company
RTN
| $156M | 0.03% |
1,632,390
-181,015
| -10% | -$19M |
|
496
Marathon Petroleum
MPC
$100B
| $155M | 0.03% |
2,972,136
-449,550
| -13% | -$22.9M |
|
|
DO
497
DELISTED
Diamond Offshore Drilling
DO
| $153M | 0.03% |
5,938,662
+41,730
| +0.7% | +$1.27M |
|
|
SE
498
DELISTED
Spectra Energy Corp Wi
SE
| $152M | 0.03% |
4,659,293
-2,030,911
| -30% | -$72.3M |
|
|
TMH
499
DELISTED
Team Health Holdings Inc
TMH
| $151M | 0.03% |
2,317,760
+4,500
| +0.2% | +$272K |
|
500
Minerals Technologies
MTX
$2.26B
| $151M | 0.03% |
2,218,357
+157,330
| +8% | +$10.9M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.